Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1383
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAKTU-
dc.date.accessioned2025-10-03T06:23:43Z-
dc.date.available2025-10-03T06:23:43Z-
dc.date.issued2024-06-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/1383-
dc.language.isoen_USen_US
dc.subjectBP805ETen_US
dc.subjectADVERSE DRUG REACTION (ADR), ADVERSE EVENT (AE), BENEFIT-RISK MANAGEMENT, CASE MANAGEMENT, SIGNAL DETECTION, DRUG SAFETY, RISK MANAGEMENT, POST-MARKETING SURVEILLANCE, CLINICAL TRIAL SAFETY, MEDICAL DEVICE SAFETY, PHARMACOVIGILANCE OFFICER, AND SAFETY MONITORINGen_US
dc.titleBP805ET PHARMACOVIGILANCEen_US
dc.typeOtheren_US
Appears in Collections:2023-2024

Files in This Item:
File Description SizeFormat 
BP805ET PHARMACOVIGILANCE.pdfBP805ET121.81 kBAdobe PDFDownload


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.